|
TBL3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.17239551400417E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.58130000497081E-08 |
| Normal-vs-Stage2 |
1.412160E-01 |
| Normal-vs-Stage3 |
2.31589999999393E-05 |
| Normal-vs-Stage4 |
6.029600E-02 |
| Stage1-vs-Stage2 |
2.571200E-01 |
| Stage1-vs-Stage3 |
8.218600E-03 |
| Stage1-vs-Stage4 |
9.671200E-01 |
| Stage2-vs-Stage3 |
1.150180E-02 |
| Stage2-vs-Stage4 |
4.629600E-01 |
| Stage3-vs-Stage4 |
1.585240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.32263122465793E-12 |
| Normal-vs-AfricanAmerican |
3.004500E-03 |
| Normal-vs-Asian |
3.140800E-01 |
| Caucasian-vs-AfricanAmerican |
2.420600E-01 |
| Caucasian-vs-Asian |
4.306600E-01 |
| AfricanAmerican-vs-Asian |
8.144800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.1228020169749E-11 |
| Normal-vs-Female |
1.53121999999506E-05 |
| Male-vs-Female |
6.279800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.021800E-03 |
| Normal-vs-Extreme_Weight |
2.57009999948821E-08 |
| Normal-vs-Obese |
2.15439999995404E-06 |
| Normal-vs-Extreme_Obese |
7.828500E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.976600E-01 |
| Normal_Weight-vs-Obese |
3.761800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.517200E-01 |
| Extreme_Weight-vs-Obese |
9.328200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.589000E-01 |
| Obese-vs-Extreme_Obese |
4.121600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.403200E-03 |
| Normal-vs-Age(41-60Yrs) |
9.12610000014524E-07 |
| Normal-vs-Age(61-80Yrs) |
1.55209955998714E-10 |
| Normal-vs-Age(81-100Yrs) |
4.659900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.990800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.293800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.059200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.318390E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.888600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.330000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.45960030120784E-10 |
| Normal-VS-Type2 PRCC |
1.432590E-04 |
| Normal-VS-KIRP CIMP |
9.718300E-03 |
| Normal-VS-Unclassified PRCC |
1.73310999999066E-05 |
| Type1 PRCC-VS-Type2 PRCC |
7.965200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.476200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.529370E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.034600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.108800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.365600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.401700E-04 |
| Normal-vs-N1 |
3.95520000000538E-05 |
| Normal-vs-N2 |
2.315200E-01 |
| N0-vs-N1 |
2.687400E-01 |
| N0-vs-N2 |
6.202800E-01 |
| N1-vs-N2 |
9.935600E-01 |
|
|
